Human Molecular Genetics, 2000, Vol. 9, No. 15 2281-2289
© 2000 Oxford University Press
Alzheimer’s disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein
Division of Demyelinating Disease and Aging, National Institute of Neuroscience, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan
Using the yeast two-hybrid system, we screened for proteins interacting with presenilin 2 (PS2) and cloned DRAL. DRAL is an LIM-only protein containing four LIM domains and an N-terminal half LIM domain. Previously DRAL has been cloned as a co-activator of the androgen receptor and as a protein interacting with a DNA replication regulatory protein, hCDC47. Our yeast two-hybrid assay showed that DRAL interacted with a hydrophilic loop region (amino acids 269–298) in the endoproteolytic N-terminal fragment of PS2, but not that of PS1, although the region 269–298 of PS2 and the corresponding PS1 sequence differ by only three amino acids. Each point mutation within this region, R275A, T280A, Q282A, R284A, N285A, P287T, I288L, F289A and S296A, in PS2 abolished the binding. This suggests that DRAL recognizes the PS2 structure specifically. The in vitro interaction was confirmed by affinity column assay and the physiological interactions between endogenous PS2 and DRAL by co-immunoprecipitation from human lung fibroblast MRC5 cells. Furthermore, in PS2-overexpressing HEK293 cells, we found an increase in the amount of DRAL in the membrane fraction and an increase in the amount of DRAL that was co-immunoprecipitated with PS2. The potential role of DRAL in the cellular signaling suggests that DRAL functions as an adaptor protein that links PS2 to an intracellular signaling.
+ To whom correspondence should be addressed. Tel: +81 42 341 2711; Fax: +81 42 346 1747; Email: tanahash@ncnp.go.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Jamali, F. Bartolomei, A. Robaglia-Schlupp, A. Massacrier, J.-C. Peragut, J. Regis, H. Dufour, R. Ravid, P. Roll, S. Pereira, et al. Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex Brain, March 1, 2006; 129(3): 625 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Kang, I. S. Yoon, E. Repetto, T. Busse, N. Yermian, L. Ie, and E. H. Koo Presenilins Mediate Phosphatidylinositol 3-Kinase/AKT and ERK Activation via Select Signaling Receptors: SELECTIVITY OF PS2 IN PLATELET-DERIVED GROWTH FACTOR SIGNALING J. Biol. Chem., September 9, 2005; 280(36): 31537 - 31547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Knoll, J. L. Pietrusz, and M. Liang Tissue-specific transcriptome responses in rats with early streptozotocin-induced diabetes Physiol Genomics, April 14, 2005; 21(2): 222 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Mistry, A. Kato, Y. H. Tran, S. Honda, T. Tsukada, Y. Takei, and S. Hirose FHL5, a novel actin-binding protein, is highly expressed in eel gill pillar cells and responds to wall tension Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1141 - R1154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Samson, N. Smyth, S. Janetzky, O. Wendler, J. M. Muller, R. Schule, H. von der Mark, K. von der Mark, and V. Wixler The LIM-only Proteins FHL2 and FHL3 Interact with {alpha}- and {beta}-Subunits of the Muscle {alpha}7{beta}1 Integrin Receptor J. Biol. Chem., July 2, 2004; 279(27): 28641 - 28652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. D. Coghill, S. Brown, D. L. Cottle, M. J. McGrath, P. A. Robinson, H. H. Nandurkar, J. M. Dyson, and C. A. Mitchell FHL3 Is an Actin-binding Protein That Regulates {alpha}-Actinin-mediated Actin Bundling: FHL3 LOCALIZES TO ACTIN STRESS FIBERS AND ENHANCES CELL SPREADING AND STRESS FIBER DISASSEMBLY J. Biol. Chem., June 20, 2003; 278(26): 24139 - 24152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lange, D. Auerbach, P. McLoughlin, E. Perriard, B. W. Schafer, J.-C. Perriard, and E. Ehler Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2 J. Cell Sci., March 14, 2003; 115(24): 4925 - 4936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Martin, R. Schneider, S. Janetzky, Z. Waibler, P. Pandur, M. Kuhl, J. Behrens, K. von der Mark, A. Starzinski-Powitz, and V. Wixler The LIM-only protein FHL2 interacts with {beta}-catenin and promotes differentiation of mouse myoblasts J. Cell Biol., October 14, 2002; 159(1): 113 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. McLoughlin, E. Ehler, G. Carlile, J. D. Licht, and B. W. Schafer The LIM-only Protein DRAL/FHL2 Interacts with and Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein J. Biol. Chem., September 27, 2002; 277(40): 37045 - 37053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. G. Amaar, G. R. Thompson, T. A. Linkhart, S.-T. Chen, D. J. Baylink, and S. Mohan Insulin-like Growth Factor-binding Protein 5 (IGFBP-5) Interacts with a Four and a Half LIM Protein 2 (FHL2) J. Biol. Chem., March 29, 2002; 277(14): 12053 - 12060. [Abstract] [Full Text] [PDF]
|
|